Results

Total Results: 1,247 records

Showing results for "adverse".

161. Screening for Obesity in Children and Adolescents: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DMDPeSf_nEUM-HrVrX6c7U
     June 20, 2017 - mental health and psychological issues, asthma, obstructive sleep apnea, orthopedic problems, and adverse … Obesity in childhood and adolescence may continue into adulthood and lead to adverse cardiovascular … Obesity in childhood and adolescence may continue into adulthood and lead to adverse cardiovascular … Five trials found no adverse or serious adverse events in the interven­ tion group. … Rates of discontinua­ tion due to adverse effects were twice as common in the interven­ tion group as

162. Draft Recommendation: Screening for Glaucoma | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/glaucoma-screening-adults-older-adults
     October 26, 2021 - There were no significant differences in risk of serious adverse events (RR, 1.14, [95% CI, 0.60 to 1.99 … ]; I 2 =32%; 3 trials; n=3,140), withdrawal due to adverse events (RR, 2.40, [95% CI, 0.71 to 19.32] … ; I 2 =0%; 5 trials; n=648), or any adverse event (RR, 1.56, [95% CI, 0.59 to 4.03]; I 2 =82%; 2 trials … ; n=1,538). 9 Two trials found that treatment was associated with increased risk of ocular adverse events … and serious adverse events.

163. Draft Recommendation: Screening for Primary-Angle Glaucoma | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/primary-angle-glaucoma-screening
     October 26, 2021 - There were no significant differences in risk of serious adverse events (RR, 1.14, [95% CI, 0.60 to 1.99 … ]; I 2 =32%; 3 trials; n=3,140), withdrawal due to adverse events (RR, 2.40, [95% CI, 0.71 to 19.32] … ; I 2 =0%; 5 trials; n=648), or any adverse event (RR, 1.56, [95% CI, 0.59 to 4.03]; I 2 =82%; 2 trials … ; n=1,538). 9 Two trials found that treatment was associated with increased risk of ocular adverse events … and serious adverse events.

164. Recommendation: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening
     December 15, 2020 - Pooled analyses found no significant differences in the risk of serious adverse events (4 trials; RR, … 0.92 [95% CI, 0.45-1.85]), any adverse event (5 trials; RR, 1.01 [95% CI, 0.90-1.11]), renal adverse … events (3 trials; RR, 1.27 [95% CI, 0.31-3.55]), or study withdrawal due to adverse events (3 trials … Pegylated interferon was associated with an increased risk of any adverse event compared with lamivudine … No significant differences in risk of serious adverse events or withdrawal due to adverse events were

165. Draft Research Plan: Prevention of Acquisition of HIV: Preexposure Prophylaxis | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/prevention-human-immunodeficiency-virus-hiv-infection-prep
     November 04, 2021 - *Harms also include renal dysfunction, adverse … with antiretroviral drug-resistant HIV, gastrointestinal harms, headaches, and discontinuation due to adverse

166. Routine Iron Supplementation During Pregnancy: Review Article (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/3XUeA-_n8KhYeS95ohoo2_
     August 03, 2020 - Safety: The potential benefits of iron supplements outweigh their adverse effects. 5. … effects II-3 Few data available regarding magnitude of adverse effects Compliance: pregnant women … Other potential adverse effects of iron have been men¬ tioned in the literature, such as claims that … When women were asked why they had not taken adequate iron, 11% responded "forgot," 8% cited "adverse … Iron deficiency anemia: adverse effects on infant psy- chomotor development.

167. Final Research Plan: Falls Prevention in Community-Dwelling Older Adults: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/falls-prevention-in-older-adults-interventions
     October 22, 2015 - The figure also depicts the possibility of harms or adverse effects occurring as a result of falls prevention … What are the adverse effects associated with primary care interventions to prevent falls in community-dwelling … Get Up & Go Test, 6-meter timed walk, Functional Reach Test, and Berg Balance Scale) KQ 2: Minor adverse

168. Archived: Final Research Plan: Falls Prevention in Community-Dwelling Older Adults: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/falls-prevention-in-older-adults-interventions-2018
     October 22, 2015 - The figure also depicts the possibility of harms or adverse effects occurring as a result of falls prevention … What are the adverse effects associated with primary care interventions to prevent falls in community-dwelling … Get Up & Go Test, 6-meter timed walk, Functional Reach Test, and Berg Balance Scale) KQ 2: Minor adverse

169. Screening and Treatment for Hypercholesterolemia in Children and Adolescents: Systematic Evidence Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/CW23r2jqogvTG2_-kBjRxH
     January 01, 2007 - Although reported adverse effects were not serious, studies were generally small and not of sufficient … Information about adverse effects of treatment was obtained from RCTs and additional sources, such … Adverse effects of screening for dyslipidemia have not been adequately studied. … Adverse effects of treatment Other drugs and combinations Table 4. … Other drugs and combinations Adverse effects of treatment 8 Table 5.

170. Evidence Summary: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/latent-tuberculosis-infection-screening
     May 02, 2023 - Treatment Discontinuation With Isoniazid Rates of treatment discontinuation because of adverse events … A total of 345 patients (1.8%) receiving isoniazid discontinued treatment because of adverse events, … The RR of discontinuation due to adverse events among patients treated with isoniazid vs placebo was … Rates of discontinuation because of adverse events were reported in all 4 included RCTs, but 1 trial … Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid:

171. Archived: Chlamydial Infection: Screening, 2001 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydial-infection-screening-2001
     January 01, 2001 - (Select Potential Adverse Effects of Screening for discussion of potential harms). … In pregnant women, chlamydial infection is associated with adverse pregnancy outcomes, including preterm … Potential Adverse Effects of Screening No studies were identified that directly examined adverse effects … Potential harms include adverse effects of both false-positive and true-positive diagnoses of an STD … inconvenience of pelvic examinations for tests employing cervical specimens, and the potential harms of adverse

172. Recommendation: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-screening
     June 09, 2020 - Few harms or serious adverse events were reported. … and control groups, including the risk of study discontinuation due to adverse events (3 trials; RR, … of naltrexone or the risk of serious adverse events (2 trials; RR, 0.32 [95% CI, 0.09-1.12]) in trials … events of brief psychosocial interventions identified harms or adverse events. … None of the other psychosocial intervention trials reported on harms or adverse events in adults. 38

173. Archived: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/cognitive-impairment-in-older-adults-screening-2014
     March 18, 2014 - It found adequate evidence that acetylcholinesterase inhibitors (AChEIs) are associated with adverse … Exercise interventions are not associated with serious adverse effects. … Adverse effects from AChEIs are common. … or serious adverse effects. … The USPSTF found adequate evidence that AChEIs are associated with adverse effects, some of which are

174. Archived: Hepatitis C Virus Infection: Screening, 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-virus-infection-screening-2004
     March 08, 2004 - current treatment regimen is long and costly and is associated with a high patient dropout rate due to adverse … Potential harms of screening and treatment include labeling, adverse treatment effects, and unnecessary … of patients receiving interferon-based therapies alone or in conjunction with ribavirin experience adverse … Patient withdrawal due to adverse effects from interferon monotherapy averaged 5 percent, and patient … withdrawal from combination therapy ranged from 10 percent to 20 percent. 2 The most common adverse

175. Final Research Plan: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/chronic-obstructive-pulmonary-disease-screening1
     October 08, 2020 - What are the adverse effects of COPD treatments in this population? … disease-specific mortality, and COPD-related morbidity; HRQoL at ≥6 months followup KQ 3: Serious adverse

176. Final Research Plan: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/chronic-obstructive-pulmonary-disease-screening
     October 08, 2020 - What are the adverse effects of COPD treatments in this population? … disease-specific mortality, and COPD-related morbidity; HRQoL at ≥6 months followup KQ 3: Serious adverse

177. Screening for Chlamydial Infection: An Evidence Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/REES__d2DxtDLhZCXQjpPW
     July 01, 2007 - Chlamydial infections are also related to adverse pregnancy outcomes, including miscarriage, pre- mature … Does screening for chlamydial infection in non- pregnant women reduce adverse health outcomes? 2. … Does screening for chlamydial infection in pregnant women reduce adverse health outcomes? 3. … RESULTS Key Question 1 Does screening for chlamydial infection in nonpreg- nant women reduce adverse … adverse health outcomes in women, or reduce the incidence of infection in women?

178. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/3HxQuXnyqHpUKNqjB7hWBw
     September 01, 2005 - What are the adverse effects of interventions? … KQ 5: What are the adverse effects of interventions? … What Are the Adverse Effects of Risk Assessment, Genetic Counseling, and Testing? … What Are the Adverse Effects of Interventions? … Table 6 also describes adverse effects.

179. Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/B73a4kJhxeaYyXK6gozbbY
     May 24, 2022 - In AREDS2, there were no differences between AREDS formulation variations and risk of serious adverse … vitamin E or pla- cebo, and no differences in risk of withdrawal due to adverse events or specific adverse … events or withdrawal due to adverse events. … events, cardiovascular events, or serious ocular adverse events Three trials found that serious ocular … adverse events were infrequent and occurred in similar proportions of patients randomized to either

180. U.S. Preventive Services Task Force Issues Draft Recommendation Statement on Medication Use to Reduce Risk of Breast Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/breast-cancer-meds-draft-rec-bulletin.pdf
     February 11, 2019 - offer risk-reducing medications to women at increased risk for breast cancer and at low risk for adverse … risk- reducing medications to women who are at increased risk for breast cancer and at low risk for adverse